Treats major depressive disorder. ANDA 77397, held by Invagen Pharms. Sertraline Hydrochloride.
As of Nov 16, 2026, ANDA 77397 (Sertraline Hydrochloride), held by Invagen Pharms, was first approved by FDA on Feb 6, 2007, with 10 approved supplements and 0 published complete response letters.
INDICATIONS AND USAGE Major Depressive Disorder – Sertraline hydrochloride is indicated for the treatment of major depressive disorder in adults. The efficacy of Sertraline hydrochloride in the treatment of a major depressive episode was established in six to eight week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III category of major depressive disorder (see Clinical Trials under CLINICAL PHARMACOLOGY ).
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 6, 2007 | Original application | Approved | None posted |
| Sertraline HydrochlorideEQ 25MG BASE · tablet;oral | Sertraline Hydrochloride | Rx |
| Sertraline HydrochlorideEQ 50MG BASE · tablet;oral | Sertraline Hydrochloride | Rx |
| Sertraline HydrochlorideEQ 100MG BASE · tablet;oral | Sertraline Hydrochloride | Rx |
| Mar 28, 2024 | Supplement 36Labeling · Standard review | Approved | None posted |
| Aug 30, 2022 | Supplement 31Labeling · Standard review | Approved | None posted |
| Feb 21, 2020 | Supplement 19Labeling · Standard review | Approved | None posted |
| Feb 21, 2020 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jun 9, 2015 | Supplement 9Labeling · Standard review | Approved | None posted |
| Jun 9, 2015 | Supplement 14Labeling · Standard review | Approved | None posted |
| Dec 21, 2012 | Supplement 6Labeling | Approved | None posted |
| Aug 31, 2009 | Supplement 3Labeling | Approved | None posted |
| Jul 16, 2008 | Supplement 2Labeling | Approved | None posted |
| Feb 7, 2008 | Supplement 1Labeling | Approved | None posted |
| Feb 6, 2007 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters